期刊文献+

盐酸替罗非班在ST段抬高急性心肌梗死治疗的临床应用 被引量:6

Analysis on the Clinical Application of Tirofiban Hydrochloride Therapy in St-elevation Acute Myocardial Infarction
暂未订购
导出
摘要 目的:观察和分析盐酸替罗非班对 ST 段抬高心梗患者急诊经皮冠状动脉介入治疗中血流的影响和临床疗效。方法选取2013年2月~2014年4月我院收治的急诊入院36例 STEMI 急性心肌梗死行 PCI 患者,随机分成两组,每组各18例,其中观察组 PCI 术前开始采用盐酸替罗非班,对照组采用常规 PCI 术,观察两组患者术前和术后冠状动脉血流情况。结果观察组患者恢复 TIMI 3级血流比例明显高于对照组,观察组术后 TIMI 血流 3级发生率为(94.4%),常规 PCI 的对照组术后 TIMI 血流为(83.3%),P <0.05。结论在对STEMI 患者进行急诊经皮冠状动脉介入治疗采用替罗非班可改善患者梗死相关血管的 TIMI 血流。 Objective To observe and analyze Tirofiban Hydrochloride of ST segment elevation myocardial infarction (AMI) patients had emergency percutaneous coronary interventional therapy in blood fiow and the infiuence of clinical curative effect. Methods From February 2013 to April 2014 emergency department of our hospital admission line 36 cases of acute myocardial infarction (STEMI PCI patients, randomly divided into two groups, each group of 18 cases, the observation group had class for PCI preoperative started using Tirofiban Hydrochloride, the control group using conventional PCI operation, observe two groups of patients with preoperative and postoperative coronary artery blood flow. Results The observation group of patients recover TIMI3 blood flow ratio is significantly higher than the control group, incidence of postoperative TIMI fiow observation group 3 for (94.4%), routine PCI postoperative TIMI fiow control group (83.3%), P〈0.05. Conclusion In patients with STEMI emergency percutaneous coronary interventional therapy using for class can improve patients with infarction related blood vessels had TIMI fiow, worthy of clinical popularization and application.
出处 《中国继续医学教育》 2014年第8期142-143,共2页 China Continuing Medical Education
关键词 盐酸替罗非班 ST段抬高心梗 PCI术 Tirofiban Hydrochloride ST segment elevation myocardial infarction PCI surgery
  • 相关文献

参考文献3

二级参考文献20

  • 1杨新春,徐立,王乐丰,葛永贵,王红石,丁枭伟,王文君,邹阳春,李惟铭,刘宇.国产替罗非班对急性心肌梗死患者急诊介入治疗术后冠状动脉血流和心肌灌注影响的研究[J].中国循环杂志,2006,21(1):4-7. 被引量:91
  • 2宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
  • 3唐强,霍勇,陈明,李建平,洪涛,郭来敬,王智,张树和,曲华清.盐酸替罗非班对急性心肌梗死急诊经皮冠状动脉介入治疗中TIMI血流影响的临床研究[J].中国介入心脏病学杂志,2006,14(2):97-99. 被引量:86
  • 4Ito H, tomooka T, Sakai N, et al. Lack of myocardial perfusion mmediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardia nfarction. Circulation, 1992, 85:1699-1705.
  • 5Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation, 1994, 89: 2514-2518.
  • 6Montalescot G, Barragan P, Wittenbery O, et al. For the ADMIRAL investigators. Platelet glycoptetion Ⅱ b/Ⅲ ainhibition with coronary stenting for acute myocardial infarction. N Eng J Med, 2001,21: 1895-1903.
  • 7Stone GW, Grines CL, Cox DA, et al. Comparision of angioplasty with stenting,with or without abeiximab, in acuete myocardial infarction. N Eng J Med, 2002, 346: 957-966.
  • 8Ndrepepa G, Kastrti A, Mehilli J, et al. Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary intervention. Circulation, 2006, 114: 2040-2046.
  • 9Resnic FS,Wainstein MW, Lee MK, et al. Ne-reflow is an independent predictor of death andmyocardial infarction after percutaneous coronary intervention. Am Heart J, 2003, 145: 42 -46.
  • 10王乐丰 杨新春 王明生 等.急性心肌梗死行急诊经皮冠状动脉介入治疗的疗效观察[J].中华心血管病杂志,2002,30:165-165.

共引文献19

同被引文献37

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部